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Background 
Interscalene analgesia is a recognized technique for the management of postoperative pain after 
major should surgery. The most effective local anesthetic concentration in this setting is still 
controversial. The aim of this study was to compare the analgesia and side-effects of a continuous 
infusion of ropivacaine 0.2% and 0.3% administered through an interscalene catheter for the first 
48 hours after surgery. 
Methods 
Eighty consecutive patients scheduled for elective open rotator cuff repair were randomized into 
two groups to receive a continuous infusion of either ropivacaine 0.2% or ropivacaine 0.3% for 48 
hours at a rate of 14 ml/h through an interscalene catheter after a preoperative bolus of 40ml 
ropivacaine 0.5% in all patients. Pain score (VAS 0-100), intensity of motor block, quality of sleep 
during the first postoperative night, morphine consumption, side-effects and patient satisfaction 
were assessed by an anesthetist masked to treatment group.  
 
Results 
Total morphine consumption was significantly reduced in group 0.3 % (12 vs. 30 mg). Quality of 
sleep was significantly better in group 0.3 % (4% vs. 27% of awakening during the first postopera-
tive night). Hand grip strength, VAS scores and side-effects were similar in both groups. 
Conclusion 
The use of ropivacaine 0.3% through an interscalene catheter for the first 48 hours after open rota-
tor cuff repair provided a significant reduction of morphine consumption, a better sleep quality for 




Patient-controlled interscalene analgesia after shoulder surgery was shown to provide better pain 
relief and a higher degree of patient satisfaction compared to patient-controlled intravenous anal-
gesia with opioids(1). Following major open shoulder surgery, ropivacaine 0.2% is associated with 
better preservation of strength in the hand and lesser paresthesias in the fingers than bupivacaine 
0.15%, while providing comparable analgesia (2).  
The influence of two different concentrations of ropivacaine used for perineural interscalene post-
operative analgesia following open rotator cuff repair has not been reported. The aim of this study 
was to compare ropivacaine 0.3% versus ropivacaine 0.2% with regard to the quality of postopera-
tive analgesia. We hypothesized better postoperative analgesia with similar degree of motor block 
in the hand and paresthesias in the fingers with ropivacaine 0.3% compared to 0.2%. The primary 
outcome was the postoperative intravenous morphine consumption 24 hours after the initial ropi-
vacaine administration through the interscalene catheter. 
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Material and Methods 
After obtaining approval of the local ethical committee (Kantonale Ethikkommission, Gesundheits-
direktion des Kantons Zürich) and written informed consent, 80 adult patients of both sexes (clas-
sified as ASA physical status I-III, age 18-75 years, weight 50-100 kg) scheduled for elective open 
rotator cuff repair were included. Exclusion criteria before the study were severe bronchopulmona-
ry disease, myocardial infarction within the last 6 months, haemostasis abnormality, known allergy 
to one of the trial drugs, known neuropathy or neurologic damage to the brachial plexus. Rando-
mization was performed during pre-anesthetic preparation, the day before surgery. Patients were 
randomized according to a computer-derived list to receive either ropivacaine 0.3% (= group 0.3%) 
or ropivacaine 0.2% (= group 0.2%) for continuous postoperative interscalene analgesia. Patients 
were excluded after randomization in case of inadequate placement of the interscalene catheter or 
accidental catheter removal before end of data assessment. The day before the operation, pati-
ents were instructed on how to use the intravenous patient-controlled analgesia (PCA) device with 
morphine for postoperative rescue analgesia. 
All patients received oral premedication with 0.1 mg/kg midazolam one hour before start of the 
anesthetic procedure. In the induction room, monitoring (electrocardiography, blood oxygen satu-
ration, non-invasive blood pressure) was applied and a 18 gauge intravenous catheter was inser-
ted in the arm not requiring surgery. The interscalene brachial plexus catheter was placed before 
induction of general anesthesia. Skin disinfection was performed with a two layer application of an 
alcoholic povidone-iodine solution (Betaseptic®, Mundipharma, Basel, Switzerland). After local 
anesthetic skin infiltration with lidocaine 1%, the interscalene brachial plexus was identified accor-
ding to the modified lateral approach (3). The proximal end of the metal inner of the 21-gauge, 70 
mm long short bevel needle (Polymedic®, Polyplex, Te me na, 78420 Carnières-sur-Seine, Fran-
ce) was connected to a nerve stimulator (Stimuplex HNS 11®; B. Braun Melsungen AG, Melsun-
gen, Germany), operated by the second person. The initial nerve stimulator setting was 1.4 mA 
current intensity, 0.1 ms impulse duration and 2 Hz impulse frequency. The final needle position 
was considered successful when a contraction of the deltoid or proximal triceps muscle was ob-
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tained with a minimal current output between 0.3 to 0.4 mA and an impulse duration of 0.1 sec. A 
20-gauge interscalene catheter (Polymedic®, Polyplex, Te me na, Bondy, France) was placed with 
the cannula over needle technique and advanced 3 cm over the tip of the needle. After subcuta-
neous tunneling through an 18-gauge intravenous catheter for 4 - 5 cm, the interscalene catheter 
was fixed with transparent adhesive tape and connected to a micro filter (200 nm). At that time, the 
initial interscalene block was performed preoperatively through the interscalene catheter with 40 
ml ropivacaine 0.5 % (200mg). Before general anesthesia, the block was assessed and consid-
ered successful, if a sensory block (inability to recognize cold) involving the supraclavicular, axil-
lary, radial and median nerves and a motor block involving the axillary (arm abduction), radial 
(forearm extension) and musculocutaneous (forearm flexion) nerves was present within 30 min 
after the administration of the local anesthetic.  
General anesthesia was performed with propofol target control infusion (Diprifusor including the 
Marsh programme for propofol, Graseby pump: Sims Graseby Limited Watford, Herts, United 
Kingdom). Fentanyl 0.25 mcg/kg and rocuronium 0.9 mg/kg were given to facilitate endotracheal 
intubation. Rocuronium supplementation was given as necessary. After induction of general a-
nesthesia, all patients received 1 g acetaminophen intravenously, that was repeated every 6 hours 
until the end of the study. No additional drug was administered through the interscalene catheter 
during the operative procedure. In all patients an open rotator cuff repair was performed by the 
same surgeon, with or without tenotomy of the biceps muscle, but without transfer of the latissimus 
dorsi muscle.  
At the end of surgery, patients were extubated and transferred to the post anesthesia recovery 
unit. Patients were connected to the intravenous PCA-device filled with morphine 1 mg/ml for res-
cue analgesia. Initial setting of the device was: 2 ml bolus and lock-out time of 10 min without ba-
sal infusion. Four hours after the initial interscalene bolus (=T0), continuous infusion through the 
interscalene catheter was started for 48h (until T48) with an infusion rate of 14 ml/h in both groups. 
The pump and syringe containing either ropivacaine 0.3% or ropivacaine 0.2% were prepared by 
our pharmacist. The syringes of both groups were identical and neither the patient, the attending 
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anesthesiologist nor the study nurse could identify patients’ group assignment. When patients ful-
filled the criteria of the modified Aldrete score (4) they were transferred to the ward.  
The following parameters were assessed in all patients by a study nurse blinded to the study drug 
concentration: Total postoperative intravenous morphine consumption through the PCA-device 
separately for the time periods T0 - T24 and T24 - T48; the time to first intravenous morphine bolus 
through the PCA-device; postoperative pain intensity in the operated shoulder at rest and with mo-
tion by the means of a visual analog scale ranging from 0 (no pain) to 100 (worst pain imaginable) 
every 8 hours postoperatively until T48 and motion was defined as passive inward and outward 
rotation of the arm and passive elbow flexion, guided by a physiotherapist. Hand grip strength was 
measured in the hand of the operated arm by means of a standard electronic pressure sensor and 
a soft rubber bulb, “the bulb grip device” 2 [see appendix 1] .Measurements were performed preo-
peratively, at T24, T48 and 6h after the end of continuous ropivacaine infusion (=T54). Motor block 
(normal, weakened or no motor function) in the hand of the operated arm was assessed at T24, T48 
and T54 by asking the patient to adduct the thumb, to flex or to extend the fingers testing the func-
tion of the ulnar, median and the radial nerve. The presence of paresthesias [Are paresthesias 
assumed to be sensory deficits from the block or a neurologic complication (or either)? Please 
clarify] in the tip of the fingers of the operated arm was recorded at T24, T48  
(assumed to be sensory deficits from the block at these time points) and T54.(defined as neurologic 
complication at this time point) Sleep quality was assessed by patient awakening during the first 
postoperative night. Only patient awakening because of pain and asking for supplementary anal-
gesia was recorded. Other disturbances interfering with sleep were not considered. Side effects 
such as nausea, vomiting, pruritus, hoarseness and Horner’s syndrome were noted. Patients were 
interviewed by phone call one month later about the presence of paresthesia or any other sensory 
or motor deficit. 
Statistical analysis 
Based on our previous experience, using patient controlled interscalene analgesia with ropivacai-
ne 0.2%, interindividual variation of postoperative intravenous morphine consumption after open 
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rotator cuff repair is about 50%. A 35% reduction of morphine consumption during the first 24h in 
patients receiving ropivacaine 0.3% was considered significant. Based on these data, a power 
analysis indicated that a sample size of 32 patients per group will be sufficient to have an 80% 
power at the 95% significance level. To increase the power we decided to include 40 patients per 
group. 
Demographic data and were compared with the Mann-Whitney test. VAS values, morphine con-
sumption and muscle strength were analyzed with the Mann-Whitney test with Bonferroni correcti-
on for multiple repeated measurements. Side-effects, the incidence of paresthesias and motor 
block were analyzed with the Chi Square test. Results are expressed as mean + SD if not otherwi-
se specified. For all determinations a P < 0.05 was considered significant. 
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Results 
Eighty-two patients were randomized (41 in each group). In both groups one interscalene catheter 
was accidentally removed at 20 and 32 hours postoperatively, respectively. Altogether 40 patients 
in each group completed the study and their data have been analyzed. A patient flow diagram ac-
cording to the CONSORT statement (5) is presented in figure 1. There was no difference between 
the groups regarding demographic patient data and data about the operative procedure (table 1). 
All the continuous ropivacaine infusions were maintained over 48 hours at a constant rate. The 
total amount of ropivacaine infused during the study was 2016 mg and 1344 mg in the group 0.3% 
and group 0.2%, respectively. 
No patient needed supplementary analgesics during surgery in either group. Total intravenous 
morphine consumption from T0 - T24 and T24 - T48 was significantly reduced in group 0.3% (7 ± 7 
mg and 4 ± 4 mg, respectively) compared to group 0.2% (14 ± 9 mg and 16 ± 17 mg, respectively). 
In the group 0.3%, the first morphine bolus was required at 20 ± 9 (range: 8 - 36) hours postopera-
tively. This was significantly later than in the group 0.2%, where patients demanded the first mor-
phine bolus 8 ± 2 (range: 1 - 11) hours postoperatively (p < 0.02). 
Pain at rest as well as pain with motion was not different between the two groups throughout the 
study. The relative decrease of the strength at T24, T48 and T54, was similar between the two 
groups.  
There was no statistically significant difference in the hand grip strength between the groups at 
T24, T48 and T54 compared with the preoperative values. 
At T48 significantly more patients in the group 0.3% had weakened thumb adduction and weak-
ened flexion of the 2nd and 3rd fingers (table 2). All other measurements showed no difference bet-
ween the groups. 
The incidence of postoperative paresthesias was similar between the two groups (table 4). The 
number of patients awakened during the first preoperative night because of pain was significantly 
higher (27%) in the 0.2% group (95 CI 13.6 – 41.4%) than in the 0.3% group (5%) (95 CI -1.7 – 
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11.7%). The occurrence of side effects (9 in the group 0.3% versus 8 in the group 0.2%) was simi-
lar between the groups. At one month no patient complained of residual paresthesias or the occur-
rence of new sensory or motor deficit.  





(n = 40) 
group 0.3% 
(n = 40) 
Gender (female/male) 8 / 32 10 / 30 
Age (years) 38 (± 15) 41 (± 14) 
Height (cm) 175 (± 7) 175 (± 9) 
Weight (kg) 73 (± 11) 78 (± 16) 
Operated side (right/left) 16 / 24 14 / 26 
Duration of surgery (min) 101 (± 30) 99 (± 34) 
 
There were no significant differences between groups. 
 
Table 2: Incidence of postoperative paresthesia in the 
fingers 
  
      
    
Postoperative finger Ropivacaine Ropivacaine 
time (hours)  0.2% group 0.3% group 
       
T24 
Dig I 
(thumb) 95 90 
 Dig II 75 75 
 Dig III 55 45 
 Dig IV 30 35 
 Dig V 20 20 
T48 
Dig I 
(thumb) 65 60 
 Dig II 45 50 
 Dig III 35 15 
 Dig IV 10 10 
 Dig V 5 5 
T56 
Dig I 
(thumb) 25 35 
 Dig II 0 15 
 Dig III 0 0 
 Dig IV 5 0 
 Dig V 5 0 
        
    
Data are expressed in %   
T24 = 24 hours postoperatively  
T48 = 48 hours postoperatively 
There were no significant  




This study demonstrated that after open rotator cuff repair continuous interscalene analgesia with 
ropivacaine 0.3% compared to ropivacaine 0.2% provided a significant reduction of morphine con-
sumption and a better sleep quality for the first postoperative night without increasing the intensity 
of motor block. The only significant difference was weakened thumb adduction and flexion of the 
2nd and 3rd fingers at 48 postoperative hours in the 0.3 ropivacaine group.  
The effects of volume and concentration of local anesthetics for continuous central or perineural 
analgesia are still a matter of controversy. Clinical studies have shown conflicting results as to 
whether similar results can be obtained by increasing either the volume or the concentration with-
out taking into account the surgeon and the type of surgery (6,7). To avoid the bias of the type of 
surgery we decided to include only one type of surgery, open rotator cuff repair, a moderate to 
severely painful surgery (8) performed by single surgeon. – A large initial bolus (40 ml) was cho-
sen to provide a complete interscalene block making supplementary application of analgesics un-
necessary during surgery. To avoid the possible confounding factor induced by the patient (use of 
PCA pump) a continuous infusion of ropivacaine without the option of patient controlled doses was 
chosen for this study, despite evidence that patient controlled doses improve analgesia for this 
type of surgery (9). Moreover, fixed-rate infusion is the optimal way to compare different local an-
esthetic concentration. The rate of infusion of 14 mL/h was chosen according to our previous ex-
periences in this surgical context, taking into account the basal rate and the average number of 
demanded doses (2).  
The hand grasp was chosen to assess motor function since this is the most reliable way to assess 
this parameter after rotator cuff repair. Hand grasp depends upon both median and ulnar functions 
and although ulnar function is likely to be less affected with interscalene analgesia, this test re-
mains clinically valid since hand weakness and paresthesia and dysesthesia in the fingers are the 
symptoms that generate patient complaints. In our data, the hand grasp was not different between 
groups at any time, despite the weakened thumb adduction and finger flexion in the 0.3 % group 
observed at 48 h. Although this difference was statistically significant, it was likely too small to in-
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fluence the overall strength of the hand grasp. Ropivacaine 0.2% was selected as “control” group 
since this concentration was shown, compared to bupivacaine 0.15% to provide similar postopera-
tive analgesia and better preservation of strength in the hand and less paresthesia in the fingers 
(2). 
Several studies have investigated the role of volume and concentration after shoulder surgery, but 
all have involved patient-controlled boluses, complicating a direct comparison with our results. 
Ilfeld et al(10) compared ropivacaine 0.2 % with a basal rate of 8 mL/h and a 2 mL patient-
controlled bolus available each hour to a basal rate of 4 mL/h and 6 mL bolus dose after moder-
ately painful surgery. The authors found that decreasing the basal rate from 8 to 4 mL/h provided 
similar analgesia, but increased the incidence of breakthrough pain, sleep disturbance and was 
associated with a lower patient satisfaction. This study emphasizes the importance of volume in 
the context of shoulder surgery, in agreement with our work where multiple nerves (suprascapular, 
axillary and supraclavicular) need to be blocked to provide analgesia after open shoulder surgery 
(11), making volume of local anesthetic a critical issue. 
In this study we showed that sleep quality during the first postoperative night was significantly bet-
ter in the 0.3% ropivacaine group. This is most likely explained by the smoother transition provided 
by 0.3% ropivacaine when the initial block performed with 0.5 % ropivacaine resolved. This was 
also shown by Ilfeld et al(10,12) who observed that patients receiving a lower basal infusion 
through an interscalene catheter experienced a higher incidence of sleep disturbances and break-
through pain.  
The absence of significant difference between the 2 groups concerning morphine induced side-
effects can be explained by first, the relatively low consumption of morphine in both groups making 
the occurrence of side-effect less likely(13). Second, the study was not powered to assess this 
outcome making a type I error possible. 
At 1 month no patient in either group had persistent paresthesias / dysesthesias or the appear-
ance of new sensori-motor deficit, this is in accordance with previous results (3). 
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In conclusion this study showed that the application of 0.3% ropivacaine compared to 0.2% after 
open rotator cuff repair reduced morphine consumption, improved the quality of the first postopera-
tive night without increasing the intensity of motor block assessed by hand grasp or side-effects. 
The results of this investigation suggest that the use of 0.3% ropivacaine through an interscalene 
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Appendix 1:  
 
Description of the hand grip strength measurement 
Hand strength was measured by means of a soft rubber bulb, the “bulb grip device”, connected to 
an electronic pressure transducer (Abbott Critical Care Systems, Abbott, Ireland). The bulb could 
be held in the hand and squeezed comfortably and was filled with water to offer resistance. The 
rubber bulb is oval-shaped, as in common use for inflating the pneumatic cuff of a conventional 
sphygmomanometer. The inlet to the bulb was sealed with a plug after being filled with water. The 
hydrostatic pressure, which increased on being squeezed, was measured with the pressure trans-
ducer connected to the bulb outlet. The transducer delivered an analog electrical signal, directly 
proportional to the pressure. The pressure transducer was of the electrical resistance type, using a 
Wheatstone bridge circuit. The bridge was supplied from a 5V stabilized DC source and its output 
amplified by means of a DC amplifier (3100) before being led to a chart recorder (Watanabet Type 
WX 441; Watanabe Instrument Corp., Tokyo, Japan) adjusted to 0.1 V/cm sensitivity and set to a 
sweep rate of 1 cm/s. The system was calibrated by use of a Bourdon-type manometer with a ran-
ge of 0 to 760 mm Hg that allowed pressure to be read from a scale, graduated in steps of 10 mm 
Hg, simultaneously. For the purpose of calibration, an external source of pressure that could be 
adjusted by means of a valve was also connected to the system. The pressure was adjusted in 
steps of approximately 50 mm Hg from 0 to 650 mm Hg, and the output voltage was recorded. The 
output signal exhibited a linear relationship of 729 mm Hg/V, or 72.9 mm Hg/cm on the chart re-
corder. Analysis of four calibration sequences showed a linear regression coefficient of 0.996 with 
a standard deviation of 617.7 mm Hg. The sensitivity of the device was mainly determined by the 
chart recorder, which could easily be read to within 61mm (corresponding to 67mm Hg). Because 
the grip strength is dependent on the position of the limbs, the control measurement (preoperative 
value) was taken in the postoperative position. All patients were able to use the device. The mea-
surement was repeated at T24, T48 and T54. Each measurement was repeated three times and the 






Figure 1: Patient flow diagram 
Study design according to the CONSORT statement (6) 
 
